In many countries annual vaccination against influenza is recommended for the elderly and the chronically ill', as it reduces influenza-associated morbidity and mortality in these groups'-'. Because the antigenic make-up of the influenza virus changes frequently and antibody titres may decline to non-protective levels within a year after vaccination'. annual vaccination seems needed.
However, there are conflicting data on the benefit of annually repeated influenza vaccination and little is known about repeated vaccination in the elderly over antibody levels were similar in previously vaccinated and unvaccinated subjects'-"'. whereas other studies showed significantly lower antibody responses in previously vaccinated subjects",".
Studies on annually repeated influenza vaccination were often performed in children and young adults7.'.'.'J, but influenza epidemics have the greatest morbidity and mortality in the elderly", not only in those with underlying disease but also in apparently healthy subjects'h-'x. Underlying disease".'", use of drugs and ageing in itself influences the immune response to influenza '"," and progressive diseases or deterioration can bias longitudinal studies. Therefore we measured the HI antibody titre for 4 years of annually repeated influenza vaccination in optimally healthy young and elderly who fulfilled the SENIECJR criteria" throughout the study. 
MATERIALS AND METHODS

Subjects
RESULTS
HI titre after single vaccination
The prevaccination HI titres of SENIEURS and JUNIEURS were similar for most strains. However, prevaccination titres were significantly lower in the SENIEURS than in the JUNILXJRS to the A/Taiwan/l/86 (HlNl) strain in 1YYl and 1992 (P=O.O03 and P = 0.001, respectively, ANOVA) and the B/Yamagata/ 16/X8 strain in 1992 (P = 0.046, ANOVA) (T&k 2).
Each year JCINICUR and S~NIEUR subjects who were vaccinated for the first time showed a significant rise in HI titre 21 days after vaccination against all influenza strains contained in the vaccine (P<O.OOl for all strains, paired Student's t-test) ( Table 2) .
Compared to the JUNIEURS, the SENIEURS had significantly lower postvaccination HI titres against the H 1Nl vaccine strain in all three years (PcO.05 for all years, ANCOVA). The postvaccination HI titrcs against the H3N2 vaccine strains were similar for the two age groups in all three years. The postvaccination titres against the influenza B strain components of the vaccine were significantly lower in the SENIEUKS than in the J~JNIELJRS (P<O.Ol for all strains, ANCOVA). with the exception of the B/Beijing/l/87 vaccine strain in 1990 for which there was no significant difference between the age groups (T&k 2). and B components of the vaccine component of the vaccine were very low in both age were higher for both age groups, being 60% or more groups. being <SO% for the SENILIIICS and slightly with some exceptions. The numbers of serologically > 50%' for the JUNII:UKS.
HI titres after annually repeated vaccination
The serological protection protcctcd subjects after vaccination with the HI N 1 and Chronological listing of serological protection rates. Rows from left to right show cohorts starting in 1990, 1991 or 1992 respectively. Numbers of subjects decrease as a result of loss to follow up. In 1993 only SENIEURS were revaccinated S, SENIEURS; J, JUNIEURS bDay 0 = prevaccination titre; day 21 = postvaccination titre "Number of subjects (number of vaccinations received) 'Vaccine strain "Year of vaccination Pre-and postvaccination serological protection rates. Numbers are percentages of subjects with protective HI titre (HI > 100 for influenza A strains; HI > 200 for influenza B strains) *P < 0.02; z* test between serological protection rates of SENIEURS and JUNIEURS **P<O.O5' McNemar test between current postvaccination serological protection rate and postvaccination serological protection rate in the previous year. Subjects due to loss to follow up were not considered in this analysis However, the SENI~UKS vaccinated for the first time in 1991 show some changes in the postvaccination titres against the HlNl strain reached after the second and third vaccination.
The postvaccination titre rises significantly after the second vaccination in comparison with the first and declines again significantly after the third vaccination but remains higher than the titrc after the first vaccination.
The rise after the second vaccination could be explained in part by a poor antigenicity of the vaccine in 1991. as we found lower HI responses after vaccination in persons entering in 1991 than in those who were vaccinated in 1990 or 1992 for the first time. This HI titre rise in the SENI~UKS from 1991 after vaccination in 1992 was also seen for the H3N2 strain A/Beijing/353/89 though this was not statistically significant. However, as the titrc against the HlNl component decreases again after the third vaccination it is more likely that the fluctuations seen in this group arc a result of group related differences.
The antibody formation after vaccination in 1902 with BiYamagatail6188 seems to be lower than the HI titre against B/Panama/45190 in the previous year. However, the subjects still have a high amount of antibody in 1992 to the vaccine strain of 1991. This lower antibody measurement against B/Yamagata/16/88 could be explained by a different avidity of B/Panama/45190 in the HI test.
The HI titre reached after vaccination was extrapolated to a measure of serological protection. The diminished protection after repeated vaccination found by Hoskins in schoolboys" was not found in the JUNIEURS and SENI~JRS of this study. Moreover, for the B strains the serological protection rates after the second vaccination were higher than after the tirst vaccination.
The serological protection rates were calculated for the antibody production against the vaccine strains, whereas the antibody titres and serological protection rates to the epidemic virus strains were not determined.
Possibly the serological protection rates given here might differ from the actual protection against a challenge with epidemic virusses.
Longitudinal observation of postvaccination titres against influenza vaccine strains presents some difficulties. Because the composition of the vaccine changes every year and because of possible differences in sensitivity of these different strains in the HI test a comparison from one year to the other must be made with caution. When the vaccine strain changed from one year to another, in the case of the H3N2 and B components, the antibody response to the vaccine
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Vaccine 1997 Volume 15 Number 12/l 3 component of the previous year was also measured (data not shown). It appeared that this hctcrologous response was sometimes cvcn better than the rcsponsc to the vaccine strain. This anamnestic phenomenon has been described before" "' and has to be taken into account when evaluating the response after rcpeatcd vaccination.
When considering prc-and postvaccination HI titres in healthy cubjccts who had not hccn vaccinated against influenza for at lcast 2 years, several diffcrcnccs between JuNffxrfcs and Sfmffmfts occurred in the quantitative antibody formation against influenza hacmagglutinin.
The finding that elderly showed a lower immune response to the A/Taiwan/l/86 (HI Nl) strain has been reported earlier'." 1Z and our data concerning the diffcrcnces in the postvaccination HI titre are in agrecmcnt with data from McElhancy et ~1."' They found lower postvaccination HI antibody levels in 1990 and 199 1 against the HlN 1 strain A/Taiwan/l/86 and the B strains BiYamagatail6188 and B/Panama/45/90 in S~NI~~IR cldcrly and young subjects of the same age groups as ours with the same vaccine strains as in our study in 1990 and 1991. They also found no diffcrcncc in postvaccination HI titrcs against the H3N2 strains between the two age groups.
A diminished HI antibody response in the cldcrly has been reported before in other studies, but also equal or even higher antibody responses have been reported".
With regard to the results of this study we may conclude that in the absence of biases like differenccs in the prcvaccination titre, underlying disease and USC of drugs, there is an age-related, vaccine strain-dependent difference in HI antibody formation after influenza vaccination.
It was suggested that the phenomenon of original antigenic sin may explain age-related differences in the antibody responses bctwccn the HINI and H3N2 vaccine strains"'.". The S~NIWRS would be optimally primed for the strains of the HlNl subtype that circulated during their childhood.
whereas the JUNII.UKS wcrc primed for Hl-strains closer rclatcd to the current HlNl strains. This could result in an age-related altered response to later influenza strains of the Hl subtype".
In contrast, the S~NIIXJKS would not have been exposed to the H3N2 subtype until the late sixtics, resulting in an equal exposure to viruses of the H3N2 subtype for both age groups.
CONCLUSIONS
There was no decline of HI antibody to the vaccine strains after annually repeated vaccination in SENIEURS and JUNIE~JRS. Moreover, for the B strains a second vaccination resulted in an even higher postvaccination titrc against the vaccine strain. Also the serological protection rates after annually repeated vaccination showed no decline. Thus annual influenza vaccination has proved to be effective in maintaining an adequate, protective HI antibody titre against the vaccine strains.
The results of this study demonstrate an association between high age and a declined responsiveness to some influenza vaccine strains, but whether this is a true senescence phenomenon requires further investigation, as WC did not see this decrease for all vaccine strains. : /.A. de Bruijn et al. 
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